Chapter
MIT and Harvard Win CRISPR Patent Case Against University of California
1:22:22 - 1:28:40 (06:17)
MIT and Harvard have won a CRISPR patent dispute against the University of California. The US Patent and Trademark Office has cancelled certain patent applications made by the University of California regarding a gene-editing technology named CRISPR Cas9.
Clips
The success of CAR T-cell therapy in treating cancer holds promise for using the same technique to treat autoimmune conditions like lupus and rheumatoid arthritis, by eliminating B-cells producing antibodies causing inflammation in the body, potentially saving millions in long-term care costs.
1:22:22 - 1:25:13 (02:50)
Summary
The success of CAR T-cell therapy in treating cancer holds promise for using the same technique to treat autoimmune conditions like lupus and rheumatoid arthritis, by eliminating B-cells producing antibodies causing inflammation in the body, potentially saving millions in long-term care costs.
ChapterMIT and Harvard Win CRISPR Patent Case Against University of California
EpisodeE71: Russia/Ukraine deep dive: escalation, risk factors, financial fallout, exit ramps and more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The US Patent and Trademark Office has ruled in favor of MIT and Harvard over UC Berkeley regarding CRISPR patents, canceling certain patent applications made by the University of California and its partners.
1:25:14 - 1:28:40 (03:25)
Summary
The US Patent and Trademark Office has ruled in favor of MIT and Harvard over UC Berkeley regarding CRISPR patents, canceling certain patent applications made by the University of California and its partners. The central dispute was which group discovered the CRISPR Cas9 gene-editing technology first.